Published in BMC Res Notes on June 06, 2013
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab (2016) 1.09
Influence of a family history of type 2 diabetes, demographic and clinical data on carotid intima-media thickness in patients with type 1 diabetes: a cross-sectional study. Cardiovasc Diabetol (2014) 0.85
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia (1989) 5.68
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia (2003) 4.33
Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes (2003) 2.51
Type 1 diabetes and coronary artery disease. Diabetes Care (2006) 2.47
The evaluation of chest pain in women. N Engl J Med (1996) 2.24
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol (1999) 1.95
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes (2008) 1.62
Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med (2004) 1.57
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol (2004) 1.49
Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med (2003) 1.43
The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med (2002) 1.36
Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes (1995) 1.29
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. Circulation (1999) 1.29
Inflammation, thrombosis and acute coronary syndromes. Diab Vasc Dis Res (2005) 1.12
Risk factors for myocardial infarction in Brazil. Am Heart J (2003) 1.11
Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care (2006) 1.05
The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: case-control analyses of risk factors for mortality. Diabetes Care (1985) 1.03
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur J Intern Med (2012) 0.95
American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease--the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol (2003) 0.92
[Oxidative stress: a review on metabolic signaling in type 1 diabetes]. Arq Bras Endocrinol Metabol (2008) 0.81
[Dyslipidemias in type 1 diabetes: a current approach]. Arq Bras Endocrinol Metabol (2008) 0.80
Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract (2009) 0.80
A multinational comparison of complications assessment in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 2. Diabetes Care (2004) 0.79
[Cardiovascular disease in diabetic women without cardiac symptoms]. Arq Bras Endocrinol Metabol (2007) 0.79
[Cardiovascular disease in type 1 diabetes mellitus]. Arq Bras Endocrinol Metabol (2008) 0.79
[Type 1 diabetic patients evolution to hypertension]. Arq Bras Endocrinol Metabol (2008) 0.78
[The impact of diabetes mellitus on the mortality of acute coronary syndromes]. Arq Bras Endocrinol Metabol (2007) 0.77
HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes. Diabetologia (2012) 0.77
Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr (2013) 1.03
The cost of type 1 diabetes: a nationwide multicentre study in Brazil. Bull World Health Organ (2013) 0.98
Heterogeneity in the costs of type 1 diabetes in a developing country: what are the determining factors? Diabetol Metab Syndr (2013) 0.77
Prevalence, awareness, and treatment of hypertension in patients with type 1 diabetes: a nationwide multicenter study in Brazil. Int J Hypertens (2013) 0.75